A Haptoglobin (HP) Structural Variant Alters the Effect of APOE Alleles on Alzheimer's Disease
Haimeng BaiiD, Adam Christian NajiD, Penelope H. BenchekiD, Logan C. DumitrescuiD, Timothy J. HohmaniD, Kara L. Hamilton‐NelsoniD, Asha R. KallianpuriD, Anthony J. GriswoldiD, Badri Narayan VardarajaniD, Eden R. MartiniD, Gary W. BeechamiD, Jennifer Elizabeth BelowiD, Gerard D. SchellenbergiD, Richard P MayeuxiD, Lindsay A. FarreriD, Margaret Ann Pericak‐VanceiD, Jonathan L. HainesiD, William S. BushiD
Abstract
BackgroundHaptoglobin (HP) is an antioxidant of apolipoprotein E (APOE), and previous reports have shown HP binds with APOE and amyloid-{beta} (A{beta}) to aid its clearance. A common structural variant of the HP gene distinguishes it into two alleles: HP1 and HP2. MethodsHP genotypes were imputed in 29 cohorts from the Alzheimers Disease (AD) Genetics Consortium (N=22,651). Associations between the HP polymorphism and AD risk and age of onset through APOE interactions were investigated using regression models. ResultsThe HP polymorphism significantly impacts AD risk and age at onset in European-descent individuals (and in meta-analysis with African Americans) by modifying both the protective effect of APOE{varepsilon}2 and the detrimental effect of APOE{varepsilon}4, especially for APOE{varepsilon}4 carriers. DiscussionThe effect modification of APOE by HP suggests adjustment and/or stratification by HP genotype is warranted when APOE risk is considered. Our findings also provided directions for further investigations on potential mechanisms behind this association.
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 11
- FWCI
- 0.39
- Field percentile
- 39th percentile
- Organism
- Assay
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- African origin haplotype protective for Alzheimer's disease in APOEϵ4 carriers: exploring potential mechanisms
Luciana Bertholim Nasciben, Karen Nuytemans, … Jeffery M. Vance·bioRxiv·Oct 24, 2024
- APOE ϵ2 vs APOE ϵ4 dosage shows sex-specific links to hippocampus-default network subregion co-variation
Chloé Savignac, Sylvia Villeneuve, … Danilo Bzdok·bioRxiv·Mar 15, 2022
- APOE ε4 effects on hippocampal atrophy in the healthy elderly reflect future cognitive decline
Linda Zhang, Miguel Calero, … Bryan Andrew Strange·bioRxiv·Jan 7, 2022
- The protective PLCG2 variants delay Alzheimer's disease onset age in APOE ϵ4 carriers
Heli Jeskanen, Sami Heikkinen, … Mikko O. Hiltunen·medRxiv·Sep 22, 2025
- Inter- and intra-chromosomal modulators of the APOE ϵ2 and ϵ4 effects on the Alzheimer's disease risk
Alireza Nazarian, Ian Philipp, … Alexander M. Kulminski·GeroSciencePeer-reviewed·Jul 9, 2022
- Characterization of APOE Christchurch carriers in 455,306 UK Biobank participants
Karen He, Ekaterina A. Khramtsova, … Mary Helen Black·medRxiv·Dec 5, 2022